David J. Mauro, Chief Medical Officer at Prelude Therapeutics Inc (PRLD), sold 29,700 shares at $28.13 ($816K) on 2021-07-06, disclosed to the SEC on 2021-07-08.
Open-market sale of $816k PRLD by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $27.17 | 10,445 | $284K | 34.8% |
| 2 | $27.17 | 10,445 | $284K | 34.8% |
| 3 | $28.13 | 4,255 | $120K | 14.7% |
| 4 | $28.13 | 4,255 | $120K | 14.7% |
| 5 | $28.84 | 300 | $9K | 1.1% |
| Total | $27.46 avg | 29,700 |
| $816K |
| 100% |
| Filing → |
| PRLD | SELL | 2021-08-09 | $930K | — | Filing → |
| PRLD | SELL | 2021-06-09 | $902K | — | Filing → |
| PRLD | SELL | 2021-05-10 | $1.2M | — | Filing → |